Skip to content

Clinical trials

Phase 2 Crohn Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Crohn Disease Phase: Phase 2 Country / region: United States Clear all

133 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200211
20033
20045
200510
20063
20074
20085
20093
20103
201110
20127
20133
20141
20154
20168
20172
20188
20195
20204
20218
20224
20233
20246
20255
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed67
Terminated34
Recruiting16
Active, not recruiting7
Withdrawn6
Not yet recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer7
AbbVie5
Janssen Research & Development, LLC5
Takeda5
Amgen4
Ferring Pharmaceuticals4
Shire4
AstraZeneca3
Bristol-Myers Squibb3
Eli Lilly and Company3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Crohn Disease133
Inflammatory Bowel Diseases33
Colitis, Ulcerative16
Inflammation7
Diarrhea3
Digestive System Diseases3
Gastrointestinal Diseases3
Intestinal Diseases3
Abdominal Pain2
Anemia, Sickle Cell2

Trials

Showing 1 to 25 of 133. Each trial links to its page on Pharma Observatory.

33 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.